Literature DB >> 10577985

Clinical implications of tumour necrosis factor alpha antagonism in patients with congestive heart failure.

G Torre-Amione1, S S Stetson, J A Farmer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10577985      PMCID： PMC1766586          DOI： 10.1136/ard.58.2008.i103

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  22 in total

1.  TNF-induced cardiomyopathy.

Authors:  S Hegewisch; H J Weh; D K Hossfeld
Journal:  Lancet       Date:  1990-02-03       Impact factor: 79.321

2.  Elevated circulating levels of tumor necrosis factor in severe chronic heart failure.

Authors:  B Levine; J Kalman; L Mayer; H M Fillit; M Packer
Journal:  N Engl J Med       Date:  1990-07-26       Impact factor: 91.245

3.  Soluble TNF binding proteins modulate the negative inotropic properties of TNF-alpha in vitro.

Authors:  S Kapadia; G Torre-Amione; T Yokoyama; D L Mann
Journal:  Am J Physiol       Date:  1995-02

Review 4.  Basic mechanisms in congestive heart failure. Recognizing the role of proinflammatory cytokines.

Authors:  D L Mann; J B Young
Journal:  Chest       Date:  1994-03       Impact factor: 9.410

5.  Negative inotropic effects of cytokines on the heart mediated by nitric oxide.

Authors:  M S Finkel; C V Oddis; T D Jacob; S C Watkins; B G Hattler; R L Simmons
Journal:  Science       Date:  1992-07-17       Impact factor: 47.728

6.  The cardiovascular response of normal humans to the administration of endotoxin.

Authors:  A F Suffredini; R E Fromm; M M Parker; M Brenner; J A Kovacs; R A Wesley; J E Parrillo
Journal:  N Engl J Med       Date:  1989-08-03       Impact factor: 91.245

7.  Cellular basis for the negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian heart.

Authors:  T Yokoyama; L Vaca; R D Rossen; W Durante; P Hazarika; D L Mann
Journal:  J Clin Invest       Date:  1993-11       Impact factor: 14.808

8.  Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure.

Authors:  R Ferrari; T Bachetti; R Confortini; C Opasich; O Febo; A Corti; G Cassani; O Visioli
Journal:  Circulation       Date:  1995-09-15       Impact factor: 29.690

9.  Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo.

Authors:  K J Van Zee; T Kohno; E Fischer; C S Rock; L L Moldawer; S F Lowry
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-01       Impact factor: 11.205

10.  Tumor necrosis factor-alpha gene and protein expression in adult feline myocardium after endotoxin administration.

Authors:  S Kapadia; J Lee; G Torre-Amione; H H Birdsall; T S Ma; D L Mann
Journal:  J Clin Invest       Date:  1995-08       Impact factor: 14.808
View more
  1 in total

Review 1.  The Inflammatory Response to Ventricular Assist Devices.

Authors:  Gemma Radley; Ina Laura Pieper; Sabrina Ali; Farah Bhatti; Catherine A Thornton
Journal:  Front Immunol       Date:  2018-11-15       Impact factor: 7.561
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.